Literature DB >> 16387370

G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis.

Omri Snir1, Gad Lavie, Anat Achiron, Ilan Bank, Taya Ben-Aharon, Benjamin Sredni, Irun R Cohen, Mathilda Mandel.   

Abstract

Autologous stem cell transplantation is being considered as treatment of severe refractory autoimmune disorders, including MS. Stem cell mobilization is achieved with granulocyte-colony stimulating factor (G-CSF), however, G-CSF administration resulted in cases of worsened clinical MS status. We studied autoreactive T-cell properties, which can promote CNS inflammation in MS. We show that G-CSF enhances MS autoreactive T cell line adhesion to the ECM proteins collagen IV and fibronectin as effectively as the proinflammatory IFNgamma and TNFalpha, known to exacerbate MS symptoms. We propose a link between clinical worsening of MS symptoms induced by G-CSF and the hyperstimulation of T cell adhesion to ECM elicited by G-CSF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16387370     DOI: 10.1016/j.jneuroim.2005.11.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

2.  Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.

Authors:  M J Haller; M A Atkinson; C H Wasserfall; T M Brusko; C E Mathews; M Hulme; M Cintron; J Shuster; K McGrail; A Posgai; D Schatz
Journal:  Clin Exp Immunol       Date:  2015-12-07       Impact factor: 4.330

3.  Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV).

Authors:  Toshiki Himeda; Takako Okuwa; Yasushi Muraki; Yoshiro Ohara
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

4.  Clone clusters in autoreactive CD4 T-cell lines from probable multiple sclerosis patients form disease-characteristic signatures.

Authors:  Mathilda Mandel; Anat Achiron; Tamir Tuller; Tilda Barliya; Gideon Rechavi; Ninette Amariglio; Ron Loewenthal; Gad Lavie
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

Review 5.  Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis.

Authors:  Anastasie M Dunn-Pirio; Benjamin M Heyman; Dan S Kaufman; Revere P Kinkel
Journal:  Curr Treat Options Neurol       Date:  2019-10-17       Impact factor: 3.598

6.  Treatment of natalizumab-associated PML with filgrastim.

Authors:  Dusan Stefoski; Roumen Balabanov; Rasha Waheed; Michael Ko; Igor J Koralnik; Fabian Sierra Morales
Journal:  Ann Clin Transl Neurol       Date:  2019-04-08       Impact factor: 4.511

Review 7.  Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.

Authors:  Bao-Guo Xiao; Chuan-Zhen Lu; Hans Link
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.